Ubs Asset Management Americas Inc Puma Biotechnology, Inc. Transaction History

Ubs Asset Management Americas Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	BUY	$8.98 - $11.6 $4,956 - $6,403	552 Added 1.33%	42,211 $387,000
Q1 2021 May 14, 2021	BUY	$9.38 - $13.63 $66,794 - $97,059	7,121 Added 20.62%	41,659 $404,000
Q4 2020 Mar 01, 2021	BUY	$7.78 - $12.13 $41,887 - $65,307	5,384 Added 18.47%	34,538 $354,000
Q2 2020 Aug 14, 2020	SELL	$7.01 - $13.24 $22,782 - $43,030	-3,250 Reduced 10.03%	29,154 $304,000
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $4,571 - $10,606	-728 Reduced 2.2%	32,404 $273,000

Q4 2019 Feb 14, 2020	BUY	$6.5 - $10.73 $15,021 - $24,797	2,311 Added 7.5%	33,132 $289,000
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $45,193 - $66,370	5,165 Added 20.13%	30,821 $331,000
Q2 2019 Aug 15, 2019	BUY	$12.3 - $35.76 $101,327 - $294,590	8,238 Added 47.3%	25,656 $0
Q1 2019 May 14, 2019	BUY	$20.77 - $42.37 $148,650 - $303,242	7,157 Added 69.75%	17,418 $0
Q4 2018 Feb 13, 2019	SELL	$20.07 - $46.7 $95,011 - $221,077	-4,734 Reduced 31.57%	10,261 $208,000
Q3 2018 Nov 14, 2018	SELL	$41.2 - $59.85 $175,553 - $255,020	-4,261 Reduced 22.13%	14,995 $0
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $74,961 - $105,924	-1,552 Reduced 7.46%	19,256 $0
Q1 2018 May 14, 2018	BUY	$59.7 - $99.25 $143,757 - $238,994	2,408 Added 13.09%	20,808 $0
Q4 2017 Feb 09, 2018	BUY	$93.85 - $132.45 $172,402 - $243,310	1,837 Added 11.09%	18,400 $0
Q3 2017 Nov 13, 2017	BUY	$72.0 - $119.75 $1.19 Million - $1.98 Million	16,563	16,563 $0

135

35.1M

264K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $226M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.